Serological studies of piperacillin antibodiesLEGER, Regina M; ARNDT, Patricia A; GARRATTY, George et al.Transfusion (Philadelphia, PA). 2008, Vol 48, Num 11, pp 2429-2434, issn 0041-1132, 6 p.Article

Piperacillin-induced immune hemolysis: new cases and a concise review of the literatureMAYER, Beate; YÜREK, Salih; SALAMA, Abdulgabar et al.Transfusion (Philadelphia, PA). 2010, Vol 50, Num 5, pp 1135-1138, issn 0041-1132, 4 p.Article

Detection of galactomannan antigenemia in patients receiving piperacillin-tazobactam and correlations between in vitro, in vivo, and clinical properties of the drug-antigen interactionWALSH, Thomas J; SHOHAM, Shmuel; PETRAITIENE, Ruta et al.Journal of clinical microbiology (Print). 2004, Vol 42, Num 10, pp 4744-4748, issn 0095-1137, 5 p.Article

Noncovalent Complexes of an Inactive Mutant of CTX-M-9 with the Substrate Piperacillin and the Corresponding ProductLEYSSENE, David; DELMAS, Julien; ROBIN, Frederic et al.Antimicrobial agents and chemotherapy. 2011, Vol 55, Num 12, pp 5660-5665, issn 0066-4804, 6 p.Article

Population Pharmacokinetic Analysis of Piperacillin in Burn PatientsSANGIL JEON; SEUNGHOON HAN; JONGTAE LEE et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 3744-3751, issn 0066-4804, 8 p.Article

Pharmacokinetics of Intravenous Piperacillin Administration in Patients Undergoing On-Line HemodiafiltrationOH, Kook-Hwan; KIM, Chiweon; LEE, Hankyu et al.Antimicrobial agents and chemotherapy. 2009, Vol 53, Num 8, pp 3266-3268, issn 0066-4804, 3 p.Article

Individualization of Piperacillin Dosing for Critically III Patients: Dosing Software To Optimize Antimicrobial TherapyFELTON, T. W; ROBERTS, J. A; LODISE, T. P et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 7, pp 4094-4102, issn 0066-4804, 9 p.Article

In vitro activity of piperacillin/tazobactam and ertapenem against Bacteroides fragilis and Escherichia coli in pure and mixed culturesDOS SANTOS, Kênia Valéria; DINIZ, Claudio Galuppo; COUTINHO, Simone Cristina et al.Journal of medical microbiology. 2007, Vol 56, Num 6, pp 798-802, issn 0022-2615, 5 p.Article

Effect of subinhibitory concentration of piperacillin/tazobactam on Pseudomonas aeruginosaFONSECA, A. P; EXTREMINA, C; FONSECA, A. F et al.Journal of medical microbiology. 2004, Vol 53, Num 9, pp 903-910, issn 0022-2615, 8 p.Article

Hypersensitivity to piperacillinCABANAS, R; MUNOZ, L; LOPEZ-SERRANO, C et al.Allergy (Copenhagen). 1998, Vol 53, Num 8, pp 819-820, issn 0105-4538Article

Effectiveness of drug use evaluation and antibiotic authorization on patients' clinical outcomes, antibiotic consumption, and antibiotic expendituresRATTANAUMPAWAN, Pinyo; SUTHA, Patama; THAMLIKITKUL, Visanu et al.American journal of infection control. 2010, Vol 38, Num 1, pp 38-43, issn 0196-6553, 6 p.Article

In-vitro activity of piperacillin and tazobactam combination against clinically significant bacteriaOBI, C. L; MAKANDIRAMBA, B; ROBERTSON, V et al.East African medical journal. 1998, Vol 75, Num 3, pp 162-165, issn 0012-835XArticle

In vitro and in vivo determination of piperacillin metabolism in humansGHIBELLINI, Giulia; BRIDGES, Arlene S; GENERAUX, Claudia N et al.Drug metabolism and disposition. 2007, Vol 35, Num 3, pp 345-349, issn 0090-9556, 5 p.Article

Comparison of Acute Kidney Injury During Treatment with Vancomycin in Combination with Piperacillin-Tazobactam or CefepimeGOMES, Diane M; SMOTHERMAN, Carmen; BIRCH, Amy et al.Pharmacotherapy. 2014, Vol 34, Num 7, pp 662-669, issn 0277-0008, 8 p.Article

Extended-Infusion versus Standard-Infusion Piperacillin-Tazobactam for Sepsis Syndromes at a Tertiary Medical CenterCUTRO, Scott R; HOLZMAN, Robert; DUBROVSKAYA, Yanina et al.Antimicrobial agents and chemotherapy. 2014, Vol 58, Num 8, pp 4470-4475, issn 0066-4804, 6 p.Article

Pipéracilline + tazobactam chez les enfants ^{(TAZOCILLINE° OU AUTRE)}La Revue Prescrire. 2013, Vol 33, Num 361, issn 0247-7750, p. 812Article

Impact of Bolus Dosing versus Continuous Infusion of Piperacillin and Tazobactam on the Development of Antimicrobial Resistance in Pseudomonas aeruginosaFELTON, T. W; GOODWIN, J; O'CONNOR, L et al.Antimicrobial agents and chemotherapy. 2013, Vol 57, Num 12, pp 5811-5819, issn 0066-4804, 9 p.Article

Antibiotic therapy for inducible AmpC β-lactamase-producing Gram-negative bacilli: what are the alternatives to carbapenems, quinolones and aminoglycosides?HARRIS, P. N. A; FERGUSON, J. K.International journal of antimicrobial agents (Print). 2012, Vol 40, Num 4, pp 297-305, issn 0924-8579, 9 p.Article

Continuous infusion of piperacillin/tazobactam in ventilator-associated pneumonia: a pilot study on efficacy and costsDUSZYNSKA, Wieslawa; SILVIO TACCONE, Fabio; SWITALA, Marcin et al.International journal of antimicrobial agents (Print). 2012, Vol 39, Num 2, pp 153-158, issn 0924-8579, 6 p.Article

Superior in vitro activity of ertapenem and piperacillin/ tazobactam against recent clinical isolates of Proteus mirabilis from intra-abdominal infections (SMART 2009―2010)HAWSER, Stephen P.International journal of antimicrobial agents (Print). 2011, Vol 38, Num 2, pp 186-187, issn 0924-8579, 2 p.Article

Pharmacodynamics of empirical antibiotic monotherapies for an intensive care unit (ICU) population based on Canadian surveillance dataZELENITSKY, Sheryl A; ARIANO, Robert E; ZHANEL, George G et al.Journal of antimicrobial chemotherapy (Print). 2011, Vol 66, Num 2, pp 343-349, issn 0305-7453, 7 p.Article

In Vitro Synergistic Activity of Combined Piperacillin and Tobramycin Against Clinical Strains of Achromobacter xylosoxidansDUEZ, J.-M; HADJIAT-SAVIOZ, M; SIEBOR, E et al.Journal of chemotherapy (Testo stampato). 2010, Vol 22, Num 2, pp 139-141, issn 1120-009X, 3 p.Article

Comparative assessment of inoculum effects on the antimicrobial activity of amoxycillin-clavulanate and piperacillin-tazobactam with extended-spectrum β-lactamase-producing and extended-spectrum β-lactamase-non-producing Escherichia coli isolatesLOPEZ-CERERO, L; PICON, E; MORILLO, C et al.Clinical microbiology and infection. 2010, Vol 16, Num 2, pp 132-136, issn 1198-743X, 5 p.Article

Daily serum piperacillin monitoring is advisable in critically ill patientsBLONDIAUX, Nicolas; WALLET, Frédéric; FAVORY, Raphaël et al.International journal of antimicrobial agents (Print). 2010, Vol 35, Num 5, pp 500-503, issn 0924-8579, 4 p.Article

First-dose and steady-state population pharmacokinetics and pharmacodynamics of piperacillin by continuous or intermittent dosing in critically ill patients with sepsisROBERTS, Jason A; KIRKPATRICK, Carl M. J; ROBERTS, Michael S et al.International journal of antimicrobial agents (Print). 2010, Vol 35, Num 2, pp 156-163, issn 0924-8579, 8 p.Article